Tumor microenvironment
161 – 170 of 1975
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Desloratadine and loratadine use associated with improved melanoma survival
- Contribution to journal › Letter
-
Mark
Hypoxia attenuates trastuzumab uptake and trastuzumab-emtansine (T-DM1) cytotoxicity through redistribution of phosphorylated caveolin-1
- Contribution to journal › Article
-
Mark
Chemotherapy, host response and molecular dynamics in periampullary cancer : The CHAMP study
- Contribution to journal › Article
-
Mark
Imaging small molecule-induced endosomal escape of siRNA
- Contribution to journal › Article
-
Mark
Women with fair phenotypes seem to confer a survival advantage in a low UV milieu. A nested matched case control study
- Contribution to journal › Article
-
Mark
Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy : an international study of 264 real-world patients
- Contribution to journal › Article
-
Mark
Women with a predisposition for diabetes have an increased risk of pregnancy complications, especially in combination with pregestational overweight
- Contribution to journal › Article
-
Mark
Efficacy and safety of tailored and dose-dense adjuvant chemotherapy and trastuzumab for resected HER2-positive breast cancer : Results from the phase 3 PANTHER trial
- Contribution to journal › Article
-
Mark
Identification and validation of VEGFR2 kinase as a target of voacangine by a systematic combination of DARTS and MSI
- Contribution to journal › Article
-
Mark
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
- Contribution to journal › Article
